BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the recipient of a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 261,100 shares, an increase of 49.7% from the February 13th total of 174,400 shares. Based on an average daily trading volume, of 454,700 shares, the days-to-cover ratio is presently 0.6 days.

BlackRock Health Sciences Term Trust Trading Up 1.4 %

Shares of NYSE:BMEZ traded up $0.21 during midday trading on Monday, reaching $15.32. The company had a trading volume of 193,587 shares, compared to its average volume of 405,160. The company has a fifty day simple moving average of $15.80 and a two-hundred day simple moving average of $15.64. BlackRock Health Sciences Term Trust has a 1-year low of $14.27 and a 1-year high of $16.75.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be given a $0.1763 dividend. This represents a $2.12 annualized dividend and a dividend yield of 13.81%. The ex-dividend date is Friday, March 14th.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

A number of large investors have recently made changes to their positions in the company. Penserra Capital Management LLC acquired a new position in shares of BlackRock Health Sciences Term Trust in the 3rd quarter valued at about $15,390,000. Raymond James Financial Inc. purchased a new position in BlackRock Health Sciences Term Trust during the fourth quarter valued at approximately $10,869,000. Absolute Investment Advisers LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust during the 4th quarter valued at $3,941,000. CF Capital LLC purchased a new position in shares of BlackRock Health Sciences Term Trust during the 4th quarter valued at $3,743,000. Finally, Wolverine Asset Management LLC increased its stake in shares of BlackRock Health Sciences Term Trust by 496.1% in the fourth quarter. Wolverine Asset Management LLC now owns 187,617 shares of the company’s stock worth $2,702,000 after acquiring an additional 156,141 shares during the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.